secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001493152-24-025714
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD completes full exercise of Series H warrants for $17.9M gross proceeds
--------------------------------------------------------------------------------

- Gross proceeds $17.9M; net proceeds $16.9M after fees.
- Warrants exercised after positive one-year C-GUARDIANS trial follow-up.
- Proceeds to fund CGuard Prime CAS delivery system and SwitchGuard TCAR NPS.
- Participants include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and Board members.
- First of four milestone-based tranches from May 2023 private placement of up to $113.6M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224025714/0001493152-24-025714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224025714/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer